Aarey Drugs & Pharmaceuticals (NSE:AAREYDRUGS) Cash-to-Debt : N/A (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Aarey Drugs & Pharmaceuticals Cash-to-Debt?

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. Aarey Drugs & Pharmaceuticals's cash to debt ratio for the quarter that ended in Dec. 2023 was N/A.

The historical rank and industry rank for Aarey Drugs & Pharmaceuticals's Cash-to-Debt or its related term are showing as below:

NSE:AAREYDRUGS' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.01 Med: 0.13 Max: 1.86
Current: 0.2

During the past 13 years, Aarey Drugs & Pharmaceuticals's highest Cash to Debt Ratio was 1.86. The lowest was 0.01. And the median was 0.13.

NSE:AAREYDRUGS's Cash-to-Debt is ranked worse than
75.66% of 1019 companies
in the Drug Manufacturers industry
Industry Median: 0.93 vs NSE:AAREYDRUGS: 0.20

Aarey Drugs & Pharmaceuticals Cash-to-Debt Historical Data

The historical data trend for Aarey Drugs & Pharmaceuticals's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

Aarey Drugs & Pharmaceuticals Cash-to-Debt Chart

Aarey Drugs & Pharmaceuticals Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Cash-to-Debt

Get a 7-Day Free Trial

0.02

0.03

0.04

0.01

0.03

Aarey Drugs & Pharmaceuticals Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Cash-to-Debt	Get a 7-Day Free Trial															N/A	0.03	N/A	0.20	N/A

Competitive Comparison of Aarey Drugs & Pharmaceuticals's Cash-to-Debt

For the Drug Manufacturers - Specialty & Generic subindustry, Aarey Drugs & Pharmaceuticals's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Aarey Drugs & Pharmaceuticals's Cash-to-Debt Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Aarey Drugs & Pharmaceuticals's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where Aarey Drugs & Pharmaceuticals's Cash-to-Debt falls into.

Aarey Drugs & Pharmaceuticals Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

Aarey Drugs & Pharmaceuticals's Cash to Debt Ratio for the fiscal year that ended in Mar. 2023 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	11.238	/	(333.575	+	43.606)
	=	0.03

Aarey Drugs & Pharmaceuticals's Cash to Debt Ratio for the quarter that ended in Dec. 2023 is calculated as:

Do not have enough data to calculate Cash to Debt ratio.

Aarey Drugs & Pharmaceuticals (NSE:AAREYDRUGS) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.

Aarey Drugs & Pharmaceuticals Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of Aarey Drugs & Pharmaceuticals's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Aarey Drugs & Pharmaceuticals (NSE:AAREYDRUGS) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Aarey Drugs & Pharmaceuticals Ltd (NSE:AAREYDRUGS) » Definitions » Cash-to-Debt

Traded in Other Exchanges

524412:India

Address

340/348, Narshi Natha Street, 107, Sahakar Bhavan, Masjid, Mumbai, MH, IND, 400 009

Website

http://www.aareydrugs.com

Aarey Drugs & Pharmaceuticals Ltd is engaged in bulk drug manufacturing and offers products for industrial applications. The company manufactures active pharmaceutical ingredients, intermediates, and specialty chemicals. It is also involved in the trading of industrial solvents and chemicals. The products offered by the company include N-Methyl urea, Dimethyl urea, Mefenamic acid, Metformin, Doxaphylline, BMD among others. The company principally carries its business operations in India.

Aarey Drugs & Pharmaceuticals (NSE:AAREYDRUGS) Headlines

No Headlines